Latest Videos |view all videos
The FDA recently approved a biosimilar (CT-P13) to infliximab, which is used for treating people with IBD, as well as people with rheumatoid arthritis ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
Aleksey Matveyenko, Ph.D., presents Role of Circadian System in Regulation of Insulin Secretion: Implications for Diabetes Prevention and Treatment.
Rozalina G. McCoy, M.D., presents Evaluation of Diabetes Care Quality and Value: Role of Optum Labs in Patient-Centered Health Care Delivery Research.
Michael F. Picco, M.D., and Michael B. Wallace, M.D., demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease.
Maria I. Vazquez Roque, M.D., discusses non-celiac gluten sensitivity (NCGS).
Imad Absah, M.D., discusses a recently published article in the Journal of Pediatric Gastroenterology and Nutrition about mucosal healing in children with celiac disease.